Tetravalent influenza vaccine (Jiangsu Simcere Vaxtec Bio-Pharmaceutical)

四价流感病毒裂解疫苗（江苏康润）

Report date: 2024/03/22 09:29:05

Base Information

Drug NameTetravalent influenza vaccine (Jiangsu Simcere Vaxtec Bio-Pharmaceutical)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, HumanCommon Cold

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusNDA/BLA

Highest Status in ChinaNDA/BLA

Originator CompaniesJiangsu Simcere Vaxtec Bio-Pharmaceutical

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Simcere Vaxtec Bio-Pharmaceutical

Inactive CompaniesN/A

Active IndicationsInfluenza, HumanCommon Cold

Inactive IndicationsN/A

Other Information

ATC CodeN/A